Metraipolis › archive › dc_3832094fc662
Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome — Europe PMC PMID:41578514
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41578514
- DOI
- 10.1097/md.0000000000046998
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:06:44.943Z
- SHA-256 of the archived text
b14f39f3c3ec10991b6efd1c19aead106f241faee94f92d8e596088d5822ad73- Stable URL of this page
https://metraipolis.com/documento/dc_3832094fc662
How to cite
Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome — Europe PMC PMID:41578514 — Europe PMC (en), https://europepmc.org/article/MED/41578514 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3832094fc662 (Metraipolis archive dc_3832094fc662, sha256 b14f39f3c3ec10991b6efd1c19aead106f241faee94f92d8e596088d5822ad73)
BibTeX
@misc{dc3832094fc662,
title = {Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome — Europe PMC PMID:41578514},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41578514},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3832094fc662; sha256 b14f39f3c3ec10991b6efd1c19aead106f241faee94f92d8e596088d5822ad73},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41578514. Agents can read the archived copy with the MCP tool read_document.